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Coronary microvascular resistance is increasingly measured as a predictor of clinical out-
comes, but there is no accepted gold-standard measurement. We compared the diagnostic
accuracy of 2 invasive indices of microvascular resistance, Doppler-derived hyperemic mi-
crovascular resistance (hMR) and thermodilution-derived index of microcirculatory resistance
(IMR), at predicting microvascular dysfunction. A total of 54 patients (61 ± 10 years) who
underwent cardiac catheterization for stable coronary artery disease (n = 10) or acute myo-
cardial infarction (n = 44) had simultaneous intracoronary pressure, Doppler flow velocity
and thermodilution flow data acquired from 74 unobstructed vessels, at rest and during
hyperemia. Three independent measurements of microvascular function were assessed, using
predefined dichotomous thresholds: (1) coronary flow reserve (CFR), the average value of
Doppler- and thermodilution-derived CFR; (2) cardiovascular magnetic resonance (CMR)
derived myocardial perfusion reserve index; and (3) CMR-derived microvascular obstruc-
tion. hMR correlated with IMR (rho = 0.41, p <0.0001). hMR had better diagnostic accuracy
than IMR to predict CFR (area under curve [AUC] 0.82 vs 0.58, p <0.001, sensitivity and
specificity 77% and 77% vs 51% and 71%) and myocardial perfusion reserve index (AUC
0.85 vs 0.72, p = 0.19, sensitivity and specificity 82% and 80% vs 64% and 75%). In pa-
tients with acute myocardial infarction, the AUCs of hMR and IMR at predicting extensive
microvascular obstruction were 0.83 and 0.72, respectively (p = 0.22, sensitivity and speci-
ficity 78% and 74% vs 44% and 91%). We conclude that these 2 invasive indices of coronary
microvascular resistance only correlate modestly and so cannot be considered equivalent.
In our study, the correlation between independent invasive and noninvasive measure-
ments of microvascular function was better with hMR than with IMR. © 2017 The Authors.
Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/). (Am J Cardiol 2018;121:1–8)
Up to 50% of patients have microvascular obstruction
(MVO)1 after primary percutaneous coronary intervention
(PPCI), resulting in worse clinical outcomes.2 MVO reflects
microvascular dysfunction (MVD) due to distal embolization
of the thrombus, endothelial dysfunction, reperfusion injury,
and intramyocardial hemorrhage.3 MVD also indicates an
adverse prognosis in the setting of stable coronary artery
disease.4 Elevated coronary microvascular resistance (MVR)
is the hallmark of MVD. Two invasive indices of MVR are
now described. Both derive MVR from simultaneous distal
coronary artery measurements of pressure and flow during
hyperemia using intra-coronary guidewires. However, the index
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of microcirculatory resistance (IMR)5 estimates flow with ther-
modilution, whereas hyperemic microvascular resistance
(hMR) incorporates Doppler flow velocity.6 Both indices have
separately been shown to predict infarct size,7,8 MVO,8 re-
gional wall motion,7 and adverse left ventricular (LV)
remodeling.7 However, to date, no study has compared hMR
and IMR against invasive and noninvasive measurements of
MVD in humans. Our study aims were to determine the level
of agreement between IMR and hMR across a range of
MVR and to compare the ability of IMR and hMR to predict
independent invasive and noninvasive measurements of
MVD.
Methods
In this prospective, 2-center study, patients who under-
went coronary angiography were enrolled at St Thomas
Hospital, London, United Kingdom, and at the VU Univer-
sity Medical Center, Amsterdam, The Netherlands. To sample
a wide range of MVR, we enrolled 2 groups: those with stable
angina and those presenting with an acute myocardial in-
farction (AMI), defined as a cardiac biomarker elevation in
association with characteristic electrocardiographic changes
and/or typical symptoms. In patients with AMI, measurements
were made in the infarct artery after percutaneous coronary
intervention and in an angiographically normal reference artery
when feasible. Exclusion criteria were hemodynamic insta-
bility or cardiogenic shock, significant LV dysfunction,
previous coronary artery bypass grafting, severe co-morbidity,
left main stem disease, and standard contraindications to car-
diovascular magnetic resonance (CMR). The protocols were
approved by the NRES London Westminster Medical Ethics
Review Committee and the Institutional Review Board of VU
University Medical Center in Amsterdam. All patients were
asked to give a written informed consent.
Measurements were taken in coronary arteries without he-
modynamically significant coronary artery disease (defined
as fractional flow reserve >0.80), or immediately after a suc-
cessful percutaneous coronary intervention in patients with
a significant coronary artery stenosis. After calibrating and
normalizing to aortic root pressure through a 6-F guiding cath-
eter, a 0.014-inch dual pressure and Doppler flow velocity
tipped sensor guidewire (ComboWire Guidewire; Philips
Volcano, San Diego, California) and a 0.014-inch pressure
wire (with temperature thermistors on the distal shaft and tip;
St Jude Medical, St. Paul, Minnesota) were advanced to the
distal vessel (>5 cm from the coronary ostia). The pressure
transducers of each wire were positioned adjacent to each
other (Figure 1). The following measurements were taken after
the administration of intracoronary nitrates (200 to 300 mcg):
aortic pressure (Pa), distal coronary artery pressure (Pd),
Doppler-derived average peak velocity, and thermodilution-
derived transit mean time.5,9 Measurements were taken at rest
and during peak hyperemia with intravenous adenosine
(140 mcg/kg/min). The following were then calculated as pre-
viously described in all patients: fractional flow reserve,10
hMR,11 IMR,5 and the Doppler-12 and thermodilution-
derived coronary flow reserve (CFR)9. In patients with AMI
the corrected TIMI frame count was also calculated.13 Doppler
flow velocity tracings of insufficient quality were discarded
from the analysis. CFR was then calculated as the average
of Doppler-derived CFR and thermodilution-derived CFR.
Investigators performing data analyses were blinded to all
clinical data. CMR scans were performed using either a 3-T
magnetic resonance (MR) scanner (St Thomas’ Hospital,
London: Achieva; Philips Healthcare, Best, The Nether-
lands) or a 1.5-T MR scanner (VU University Medical
Center, Amsterdam: Magnetom Avanto; Siemens, Erlangen,
Germany). Cine images were acquired in 2-, 3-, and 4-chamber
orientations and in a whole LV short-axis stack using a
steady-state free precession sequence. CMR high-resolution
stress (adenosine 140 mcg/kg/min for 4 minutes) and rest
perfusion scans were performed exclusively on a 3-T MR
scanner, within 48 hours of MVR measurements, using
gadolinium contrast. In patients with AMI, late gadolinium
enhancement images were obtained 15 minutes after the
last CMR contrast injection. LV ejection fraction and LV
mass were calculated from cine images. The myocardial
perfusion reserve index (MPRI) was derived from the
semiquantitative perfusion analysis, as previously de-
scribed, to provide territory-specific values to match invasive
data, using a 16-segment American Heart Association model
(Supplementary Figure S7 online data supplement).14 MVO
was manually delineated from late gadolinium enhance-
ment images as an area of hypoenhancement within an
infarcted LV mass (Figure 1).15 Extensive MVO was a pre-
defined dichotomous variable when there was >2 ml MVO
volume present.16 Further details on the methods can be found
in the online data supplement.
Statistical analyses were performed using GraphPad Prism
6.0 (GraphPad, San Diego, California) and MedCalc Statis-
tical Software version 12.7.8 (MedCalc Software, Ostend,
Belgium). Continuous variables were tested for normality using
the Shapiro-Wilk test and were presented as mean ± stan-
dard deviation when data were normally distributed or as
median with interquartile range when data were non-normally
distributed. Correlations between hMR and IMR, and each
with CFR, MPRI, and MVO, were assessed using Spear-
man (rho) analyses. MVD was defined dichotomously for each
independent outcome variable: CFR <2.0,17 MPRI <1.0,14,18
and extensive MVO.16 Receiver operating characteristic analy-
sis was performed to determine the best cut-off values for
predicting MVD using each method, and comparisons were
made using the DeLong method. P values of <0.05 were con-
sidered significant.
Results
The flow of patients through the study is shown in Figure 2.
Two patients (4%) were excluded because of poor quality
Doppler traces, leaving 54 patients (10 patients with stable
angina and 44 patients with AMI: 33 with ST-segment el-
evation myocardial infarction [STEMI] and 11 with non-
STEMI) with 74 complete invasive physiology datasets
(Table 1). Invasive and CMR physiologic data were ac-
quired in 40 patients (8 patients with stable angina and 32
patients with AMI: 27 with STEMI and 5 with non-STEMI;
Table 2). The time between invasive measurements and CMR
scans was 24 hours (7 to 49 hours). In the enrolled popula-
tion (see Table 1), the hMR was 2.60 (1.99 to 3.43) mm
Hg·cm-1·s and the IMR was 19.0 (13.0 to 29.8) U. hMR sig-
nificantly correlated with IMR (rho = 0.39, p = 0.0006;
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Figure 3). Baseline and hyperemic thermodilution transit mean
time values were 0.56 (0.35 to 0.92) seconds and 0.27 (0.18
to 0.39) seconds, respectively. Baseline and hyperemic Doppler
average peak velocity values were 15.3 (12.0 to 20.7) cm·s-1
and 29.4 (21.5 to 37.6) cm·s-1, respectively. Transit mean time
values correlated significantly with values at baseline
(rho = −0.36, p = 0.002) and hyperemia (rho = −0.41,
p = 0.0003). There was a strong correlation between Doppler-
derived CFR 1.90 (1.46 to 2.21) and thermodilution-derived
CFR 1.82 (1.50 to 2.47) (rho = 0.61, p <0.0001).
hMR and IMR correlated with CFR (hMR, rho = −0.52,
p <0.0001; IMR, rho = −0.24, p = 0.04). hMR values were
higher in patients with MVD defined dichotomously by CFR
(3.16 vs 2.12 mm Hg·cm-1·s, p <0.0001; Figure 4), but there
was no difference between groups using IMR (22 vs 19 U,
p = 0.25; Figure 4). Delong receiver-operator characteristic
analysis demonstrated that hMR had superior diagnostic
accuracy compared with IMR at predicting MVD: area under
curve (AUC) 0.82 versus 0.58, p <0.001 (Figure 5). A thresh-
old of ≥ 2.5 mm Hg·cm-1·s for hMR provided the highest
sensitivity (0.77) and specificity (0.77) for detecting MVD,
whereas the optimal threshold for IMR was ≥21.5 U, with a
sensitivity of 0.51 and a specificity of 0.71.
hMR was significantly correlated with MPRI (rho = −0.58,
p <0.001), but IMR was not (rho = −0.27, p = 0.15). hMR
and IMR values were higher in patients with MVD, defined
dichotomously by MPRI (hMR: 3.43 vs 2.11 mm Hg·cm-1·s,
p <0.001, IMR: 27.0 vs 18.4 U, p = 0.02; Figure 4). Receiver-
operator characteristic analysis showed that hMR had a
numerically superior diagnostic accuracy over IMR to predict
MPRI, although the difference did not reach statistical sig-
nificance (AUC, 0.85 vs 0.72, p = 0.19) (Figure 6).A threshold
of ≥2.5 mm Hg·cm-1·s for hMR provided the optimal sen-
sitivity (0.82) and specificity (0.80) for predicting MVD. The
Figure 1. Cardiac catheterization protocol used to derive invasive measurements of microvascular resistance. (A) Combomap Console (Volcano Corporation,
San Diego, California) displaying continuous aortic and Pd and Doppler flow velocity. (B) Coronary angiographic image demonstrating a 0.014-inch ComboWire
(Volcano Corporation) and a 0.014-inch pressure wire (St Jude Medical, Uppsala, Sweden) placed in equivalent positions in the distal circumflex artery.
(C) St Jude Console (St Jude Medical) displaying aortic and Pd, and 3 Tmn measurements at both baseline and during steady-state hyperemia. (D) Late gado-
linium enhancement cardiac magnetic resonance image 5 days after a revascularized acute ST-segment elevation myocardial infarction of the left anterior
descending coronary artery. This short-axis view shows a hypoenhanced core of MVO within a hyperenhanced area of infarcted tissue in the anteroseptal
myocardium. hMR = hyperemic microvascular resistance; hSR = hyperemic stenotic resistance; iPa = instantaneous aortic pressure; iPd = instantaneous distal
coronary artery pressure.
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best cut-off value for IMR was ≥24.0 U, with poorer sensi-
tivity (0.64) and specificity (0.75).
In the patients with AMI with invasive and CMR data (see
Figure 2), MVO was visible in 42% of the patients. In these
patients, the MVO volume was 3.2 ml (2.0 to 5.2). Both
infarct-related artery hMR and IMR measurements corre-
lated with MVO volume (hMR, rho = 0.46, p = 0.001; IMR,
rho = 0.36, p = 0.01). hMR and IMR values were both sig-
nificantly higher when there was evidence of extensive MVO
(hMR 3.74 vs 2.60 mm Hg·cm-1·s, p = 0.003; IMR 23.5 vs
19.0 U, p = 0.04; Figure 4). Receiver-operator characteris-
tic analysis demonstrated that hMR had a numerically superior
diagnostic accuracy over IMR to predict the presence of ex-
tensive MVO (superior sensitivity), but this was not significant
(AUC 0.83 vs 0.72, p = 0.22) (Figure 6). A threshold of
≥ 3.25 mm Hg·cm-1·s provided the highest sensitivity (0.78)
and specificity (0.74) for detecting extensive MVO. The best
cutoff for IMR was ≥40 U with sensitivity (0.44) and speci-
ficity (0.91). In addition, hMR had superior diagnostic accuracy
Figure 2. Flow of patients through the study. Two patients (4%) were ex-
cluded because of poor quality Doppler traces, leaving 54 patients (10 patients
with stable angina and 44 patients with AMI: 33 with STEMI and 11 with
non-STEMI) with 74 complete invasive physiology datasets (Table 1; those
with a full hMR, an index of microcirculatory resistance, and a coronary
flow reserve dataset from at least 1 vessel). Invasive and CMR physiologic
data were acquired in 40 patients (Table 2; 8 patients with stable angina and
32 patients with AMI: 27 with STEMI and 5 with non-STEMI). Fourteen
patients were excluded because of claustrophobia, patient preference (de-
creased), being too obese to have a CMR scan (logistics), or because of poor
quality perfusion data from an inadequate breath-hold. * CMR infarct size
and MVO measurements were obtained in all 32 patients with AMI (27 with
STEMI and 5 with non-STEMI), whereas CMR perfusion was only per-
formed on high-resolution 3-T perfusion scans in 23 patients (8 patients with
stable angina and 15 patients with AMI).
Figure 3. Correlation of hMR versus the IMR.
Table 1
Clinical demographics and angiographic characteristics of the 54 patients
Variable AMI Patients
(n = 44)
Angina Pectoris
(n = 10)
Men 40 (90) 9 (90)
Age (years) 60.2 ± 10.6 61.7 ± 9.0
Body Mass Index (kg/m2) 26.9 ± 3.7 29.8 ± 3.4
Hypertension 29 (64) 7 (64)
Diabetes Mellitus 21 (47) 3 (27)
Hypercholesterolemia 36 (80) 9 (82)
Smoker 30 (67) 8 (73)
Non-culprit/Non-treated Measurements
LAD / LC / Right 9/2/7 6/3/0
Fractional Flow Reserve 0.95 ± 0.06 0.89 ± 0.04
Culprit/treated Measurements
LAD/LC/Right 24 / 7 / 10 3 / 0 / 3
Fractional Flow Reserve (post PCI) 0.93 ± 0.06 0.92 ± 0.05
Acute Myocardial Infarction
Characteristics
Corrected TIMI frame count 17 (10–26) n/a
Peak Troponin T, µg/L 1075 (203–7189) n/a
Data are number (%), mean±SD or median (IQR).
LAD = left anterior descending; LC = left circumflex artery; PCI = per-
cutaneous coronary intervention.
Table 2
Cardiac Magnetic Resonance (CMR) data
Variable All patients
Duration between invasive measurements and CMR, hours 24 (7, 49)
Semi-quantitative CMR analysis (31 datasets from
23 patients*)
Myocardial Perfusion Reserve Index 1.07 (0.86, 1.49)
Volumetric analysis (40 datasets from 40 patients)
Left Ventricular End Diastolic Volume, ml 174 (150, 200)
Left Ventricular End Systolic Volume, ml 81 (55, 119)
Left Ventricular Ejection Fraction, % 52 (41, 63)
Microvascular Obstruction (32 datasets from 32 patients)
Evidence of Microvascular Obstruction, number 13
Evidence of extensive† Microvascular Obstruction,
number
10
Quantitative infarct size analysis (32 datasets from
32 patients)
Infarct Size, g 22.5 (5.1, 35.2)
Infarct Size % of Left Ventricular mass 14.3 (4.5, 24.8)
Data are number, median (interquartile range) or mean ± SD.
* Includes MPRI values from corresponding culprit / non-culprit vessels.
† More than 2mls volume.
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Figure 4. hMR and IMR invasively measured in patients with and without evidence of microvascular dysfunction as evidenced by (A) invasive CFR,
(B) noninvasive myocardial perfusion reserve index, and (C) noninvasive extensive microvascular obstruction. Boxes represent the median and the interquartile
range with whiskers as the 10th to 90th percentiles, and values outside the 10th to the 90th percentiles are presented as individual data points.
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over IMR to predict the presence of any MVO, but this dif-
ference was not significant (AUC 0.75 vs 0.66).
Discussion
To our knowledge, this is the first study in humans to have
simultaneously assessed the correlation of 2 invasive indices
of MVR, Doppler-derived hMR and thermodilution-derived
IMR, against each other and against independent measurements
of MVD. The main findings of this study are (1) hMR and
IMR correlate modestly with each other, and therefore cannot
be considered equivalent predictors of MVD; (2) hMR had
superior diagnostic accuracy over IMR to predict MVD de-
termined invasively by CFR; (3) hMR had a clinically superior
sensitivity over IMR to predict MVD determined by cardiac
magnetic resonance-derived MPRI and extensive MVO, but
there were no statistically significant differences observed;
(4) an hMR threshold of ≥2.5 mm Hg·cm-1·s and an IMR
threshold from 21.5 to 24 U were optimal for predicting MVD
determined by CFR and MPRI; (5) in the infarct related artery
after an AMI, an hMR threshold of ≥3.25 mm Hg·cm-1·s and
an IMR threshold of ≥40 U were optimal for predicting MVD
determined by extensive MVO.
Optimal assessment of MVD enables better risk stratifi-
cation for adverse cardiovascular outcomes. In addition, in
the setting ofAMI after PPCI, instant MVR measurement could
help select patients most likely to benefit from adjunctive phar-
macotherapy (e.g., intracoronary GpIIbIIIa inhibitors19,20). An
accurate assessment of MVR can be performed safely in the
cardiac catheter laboratory, across a broad spectrum of MVD
in patients with AMI and stable angina, using either hMR or
IMR. However, although equivalent hyperemic distal pres-
sures were obtained from the 2 intracoronary guidewires, the
overall correlation between hMR and IMR was far from strong
(rho = 0.39). Therefore, discrepancies in the MVR measure-
ments relate to differences in the estimation of flow. Each
technique has inherent theoretical assumptions that are chal-
lenged in varying pathophysiologic states. Thermodilution-
derived transit time is a surrogate of absolute coronary blood
flow and is not indexed to the amount of myocardium sub-
tended. Doppler flow velocity, however, decreases only by a
fraction as branching occurs. Therefore, hMR may be less
influenced by the amount of myocardium subtended than IMR.
Previous investigators have reported a wide range of
prognostic thresholds for both hMR (2.5 to 3.6 mm Hg·cm-1·s16)
and IMR (32 to 40 U7,21) in patients who have experienced
a recent AMI. The thresholds we identified for hMR and
IMR to predict the presence of MVO are similar to that pre-
viously reported.8,16,22 The thresholds for predicting MVD
with CFR and MPRI, which are more sensitive measure-
ments of MVD, are understandably lower for both hMR and
IMR. Recently, Patel et al measured hMR and IMR directly
Figure 5. Performance of invasive indexes of microvascular resistance versus
an invasive standard of coronary microvascular dysfunction: receiver oper-
ating characteristic analysis. Accuracy of hMR versus IMR in predicting a
CFR of < 2.0 in vessels with a fractional flow reserve of >0.80. The optimal
thresholds were ≥2.5 mm Hg·cm-1·s for hMR and ≥21.5 U for IMR.
Figure 6. Performance of invasive indexes of microvascular resistance versus noninvasive markers of coronary microvascular dysfunction: receiver operating
characteristic analysis. (A) Accuracy of hMR and IMR in predicting the myocardial perfusion reserve index of <1.0, a noninvasive marker of coronary mi-
crovascular dysfunction. The calculated cut-off values were ≥2.5 mm Hg·cm-1·s for hMR and ≥25 U for IMR. (B) Accuracy of hMR and IMR in predicting
the presence or the absence of extensive microvascular obstruction (>2ml),19 a noninvasive standard of coronary microvascular dysfunction in acute myocar-
dial infarction. The best cut-off values were ≥3.25 mm Hg·cm-1·s for hMR and ≥40 U for IMR.
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after PPCI in 34 patients recruited with STEMI.23 Patel et al
demonstrated that hMR had a superiority trend over IMR in
predicting parameters of infarct size and impaired LV ejec-
tion fraction, but this failed to reach statistical significance.23
However, they did not include measurements of MVD in this
comparison.
Several study limitations should be acknowledged. First,
notwithstanding the detailed physiologic characterization of
our study cohort, this is a study with a relatively small sample
size. Second, there is currently no true reference standard mea-
surement of microvascular function. In our study, we used
multiple distinct methods of assessing microvascular function,
which we believe represents the best available composite
clinical surrogate for a true reference standard. CFR was
chosen as the invasive measurement of MVD because it was
readily obtainable in every patient and is utilized in clinical
practice as a marker of MVD.17 Although a CFR threshold
of <2.0 in unobstructed coronary arteries to predict MVD is
somewhat controversial, hMR also performed better than IMR
to predict CFR thresholds of <2.3 and <2.5 (used in previ-
ous studies to define MVD). Third, although we acknowledge
that CFR can be affected by several hemodynamic factors and
loading conditions, these conditions were minimized by en-
suring that (1) baseline and peak measurements for Doppler
and thermodilution were taken immediately after each other;
(2) all hyperemic measurements were taken during steady-
state hyperemia with intravenous adenosine; and (3) no other
drugs or intravenous fluids were administered between Doppler
and thermodilution measurements. Fourth, CMR late gado-
linium enhancement was performed up to 6 days after AMI
and therefore the measurements may be confounded by partial
resolution of transient MVD after AMI. Nevertheless, this
would be expected to affect both hMR and IMR to the same
extent. Finally, it should be noted that there is no accepted
dichotomous threshold for defining MPRI and MVO, and the
values we have used may differ from some studies.
This prospective 2-center study assessed the correlation
between Doppler-derived hyperemic MVR and thermodilution-
derived IMR against each other and against independent
reference measurements of MVD. We found that these 2 in-
vasive indices are both predictors of MVD. However, only
a modest correlation was found between hMR and IMR.
Therefore, these measurements cannot be considered equiva-
lent predictors of MVD.
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